Mycotic vulvovaginitis;Vulvovaginiti micotiche

Recenti Progressi in Medicina

Volumn 88, Issue 10, 1997, Pages 479-484

  Margariti, Pasquale Alessandro ^a,b   Astorri, Anna Laura ^a   Mastromarino, Carmen ^a   Morace, Giulia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE   (Italy)

Author keywords

antifungal therapy; Candida; vulvovaginitis

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; CLOTRIMAZOLE; ECONAZOLE; FENTICONAZOLE; ISOCONAZOLE; ITRACONAZOLE; MEPARTRICIN; METRONIDAZOLE; MICONAZOLE; NIFURATEL; NYSTATIN; TERCONAZOLE; TINIDAZOLE; TIOCONAZOLE;

CANDIDA ALBICANS; CANDIDIASIS; CLINICAL FEATURE; DRUG CHOICE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TOPICAL DRUG ADMINISTRATION; VULVOVAGINITIS;

ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; VULVOVAGINITIS;

EID: 0030880316     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Agatensi L, Franchi F, Mondello F, Bevilacqua RL, Ceddia T. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. J Clin Pathol 1991; 44: 826-30.
2. Bergman JJ, Berg AO, Schneeweiss R, Heidrich FE. Clinical comparison of microscopic and colture techniques in the diagnosis of Candida vaginitis. J Fam Pract 1984; 18: 549-52.
3. Bertholf ME, Stafford MJ. Colonization of Candida albicans in vagina, rectum, and mouth. J Fam Pract 1983; 16: 919-24.
4. Calzolari E, Manzari V, Rahman Jaradat A. L'incidenza della candidosi vulvo-vaginale asintomatica nella gestante. Pat Clin Ost Ginec 1981; 1: 70-4.
5. Cassone A. Candida e candidosi. Fed Med 1985: XXXVIII: 1018-30.
6. Creatsas GC, Charalambidis VM, Zagotzido EH, Anthopoulou HN, Michailidis DC, Aravantinos DI. Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole. Clin Ther 1993; 15: 662-71.
7. Di Giorgio R, Ruggiero M, Poti M, et al. Le infezioni genitali da Candida. Giorn It Ostet Gin 1995; (XVII) VII: 186-92.
8. Dupont PF. Candida albicans, the opportunist. A cellular and molecular perspective. J Am Pediatr Med Assoc 1995; 85: 104-15.
9. Evrard JR. Vulvovaginal infections. In: Nicols ed. Ambulatory Gynecology. Philadelphia: Harper & Row 1985.
10. Fegeler W, Van Husen N, Witting C. Mycologische Befunde bei Gastroskopiepatienten-Möglichkeiten einer differenzierten Bewertung. Mykosen 1983; 26: 82-8.
11. Heykants J, Van Peer A, Laurijsen K, Meuldermans W, Woestenborghs R, Cauwenbergh G. Pharmacokinetics of oral antifungals and their clinical implications. Br J Clin Pract Symp 1990; 71 (suppl 1): 50-6.
12. Horowitz BJ. Mycotic vulvovaginitis: a broad overwiew. Am J Obstet Gynecol 1991; 165: 1188-92.
13. Horowitz BJ, Giaquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992; 32: 248-55.
14. Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy: analysis of 33 cases. Gastroenterology 1984; 86: 503-13.
15. Lindeque BG, Van Niekerk WA. Treatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessary. S Am Med J 1984: 65: 123-6.
16. Margariti PA. Le infezioni in ginecologia e le malattie sessualmente trasmissibili. Bologna: Alfa Wassermann 1996.
17. Mercure S, Poirier S, Lemay G, Auger P, Montplaisir S, de-Repentigny L, Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis. J Infect Dis 1993; 168: 502-7.
18. Miles MR, Olsen L, Rogers A. Recurrent vaginal candidiasis: importance of an intestinal reservoir. JAMA 1977; 238: 1836-7.
19. Nyirjesy P, Seeney SM, Grody MH, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am Obstet Gynecol 1995; 73: 820-3.
20. O'Conner MI, Sobel JD. Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida, albicans. J Infect Dis 1986; 154: 358-63.
21. Ogunbanjo BO. Isolation of yeast from male contacts of women with vaginal candidosis. Genitourin Med 1988; 64: 135-6.
22. Schlosser RL, Zubcov A, Bollinger M, Kuhnert M, Loeweni V. Kongenitale Candidainfektionen. Monatsschr-Kinderheilkd 1993; 141: 864-7.
23. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152: 924-35.
24. Sobel JD Vasquez J, Lynch M, Meriwether C, Zervos M. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis 1993; 16: 93-9.
25. Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Am J Obstet Gynecol 1995; 172: 1263-8.
26. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992; 14 (suppl 1): 48-53.
27. Spinillo A, Capuzzo E, Egbe TO, Baltaro F, Nicola S, Piazzi G. Torulopsis glabrata vaginitis. Obstet Gynecol 1985; 85: 993-8.
28. Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vulvovaginal candidiasis. Contraception 1995; 51: 293-7.
29. Van Doom HC, Coelingh-Bennink F. Vaginal infection caused by Saccharomyces cerevisiae. Ned Tijdschr Geneeskd 1995; 139: 1093-5.
30. Volpi E. Le infezioni vaginali. Torino: Minerva Medica 1987.